We are live on ! Find out more
SBBP

Strongbridge Biopharma plc.
SBBP

Delisted

SBBP was delisted on the 5th of October, 2021.

Back to rankings

60 hedge funds and large institutions have $48.8M invested in Strongbridge Biopharma plc. in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

11% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 18

3% more funds holding

Funds holding: 58 → 60 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $49.7M → $48.8M (-$898K)

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
1.32%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
20
Reduced
18
Closed
11
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$8.82M
2
BFM
Boothbay Fund Management
New York
+$1.01M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$925K
4
JP Morgan Chase
JP Morgan Chase
New York
+$923K
5
Renaissance Technologies
Renaissance Technologies
New York
+$839K

Top Sellers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
-$2.63M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$1.73M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.36M
4
SCM
Stonepine Capital Management
Oregon
-$903K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$878K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Caxton Corporation
New Jersey
$12.5M – – –
NMC
2
NEA Management Company
Maryland
$7.83M – – –
IC
3
Ikarian Capital
Texas
$6.41M +$8.82M +3,392,787 New
BlackRock
4
BlackRock
New York
$3.9M +$200K +76,865 +4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.42M +$925K +355,876 +25%
Hudson Bay Capital Management
6
Hudson Bay Capital Management
Connecticut
$2.66M -$1.73M -665,581 -32%
Renaissance Technologies
7
Renaissance Technologies
New York
$1.82M +$839K +322,728 +50%
State Street
8
State Street
Massachusetts
$1.43M +$209K +80,569 +12%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1M +$352K +135,490 +34%
6CM
10
683 Capital Management
New York
$868K -$390K -150,000 -25%
JP Morgan Chase
11
JP Morgan Chase
New York
$799K +$923K +354,945 +524%
Northern Trust
12
Northern Trust
Illinois
$766K +$24.2K +9,324 +2%
BFM
13
Boothbay Fund Management
New York
$734K +$1.01M +388,309 New
Morgan Stanley
14
Morgan Stanley
New York
$444K +$482K +185,394 +374%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$443K -$878K -337,931 -59%
DT
16
Diversified Trust
Tennessee
$375K – – –
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$372K +$511K +196,648 New
DMK
18
David M. Knott
$344K +$213K +81,800 +82%
Citadel Advisors
19
Citadel Advisors
Florida
$235K +$284K +109,171 +722%
PPA
20
Parametric Portfolio Associates
Washington
$208K +$1.83K +705 +0.6%
Wells Fargo
21
Wells Fargo
California
$199K +$36.3K +13,980 +15%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$199K +$148K +56,870 +116%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$187K +$4.54K +1,747 +2%
Two Sigma Investments
24
Two Sigma Investments
New York
$148K +$203K +78,047 New
Charles Schwab
25
Charles Schwab
California
$143K – – –
1
2 3

SBBP Hedge Fund Activity: Q1 2020 in Review

60 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q1 2020, worth a combined $48.8M — down 1.8% from $49.7M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new SBBP positions and 11 closed out — a net gain of 2 holders — while 20 added to existing stakes and 18 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $8.82M. The largest seller was Prosight Management, exiting entirely with an estimated $2.63M sold.

  • 60 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q1 2020, up from 58 in Q4 2019.
  • Funds reported $48.8M of Strongbridge Biopharma plc. stock for Q1 2020, down 1.8% quarter-over-quarter.
  • 13 funds opened new Strongbridge Biopharma plc. positions in Q1 2020 and 11 closed out, a net change of +2 holders.
  • The largest Strongbridge Biopharma plc. buyer in Q1 2020 was Ikarian Capital, an estimated $8.82M added.
  • The largest Strongbridge Biopharma plc. seller in Q1 2020 was Prosight Management, an estimated $2.63M sold.

Based on aggregated 13F filings for Q1 2020.